• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[三种不同脱钙溶液在乳腺癌骨转移标本中的对比研究]

[Comparative study of three different decalcifying solutions in bone metastasis specimens with breast cancer].

作者信息

Wu H Y, Wang T, Chen K L, Fan Z W, Pu X H, Zhang B, Fan X S, Meng F Q

机构信息

Department of Pathology, the Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2017 Aug 8;46(8):536-541. doi: 10.3760/cma.j.issn.0529-5807.2017.08.004.

DOI:10.3760/cma.j.issn.0529-5807.2017.08.004
PMID:28810293
Abstract

To investigate the optimal strategy for immunohistochemical (IHC) staining in bone metastasis specimens from breast cancer. Twenty-eight bone metastases specimens from breast cancers were divided into three groups and subjected to different decalcifying agents (group A-10% nitrate, group B-EDTA decalcification, and group C-imported decalcifying solution RapidCal). The effects of those on HE and IHC staining for Ki-67, ER, PR, GATA3, RANK, RANKL, HER2 and HER2 FISH results were assessed. There were no significant differences among three groups in HE morphology and IHC staining. Antigen content in the RapidCal group were all intact; the EDTA group showed a similar staining rate, which was better than the nitrate group (<0.05). Nitrate group showed marked reduction in nuclear Ki-67 staining, but the loss of cytoplasmic antigens (RANK, RANKL) was less than cell membrane antigen (HER2). For FISH, the RapidCal group and EDTA group showed same results, concordant with IHC staining results. The expression of HER2 protein in the nitric acid group was significantly decreased and chromosome 17 labelling was lost (<0.05). RapidCal treated bone metastases specimens from breast cancer show excellent sample quality in morphological, IHC and FISH results compared with traditional decalcifying agents. Owing to the longer time of EDTA decalcification, the new decalcifying agent RapidCal plays an important role in quality control and clinical application.

摘要

探讨乳腺癌骨转移标本免疫组织化学(IHC)染色的最佳策略。将28例乳腺癌骨转移标本分为三组,分别使用不同的脱钙剂(A组-10%硝酸,B组-乙二胺四乙酸(EDTA)脱钙,C组-进口脱钙液RapidCal)。评估它们对苏木精-伊红(HE)染色以及Ki-67、雌激素受体(ER)、孕激素受体(PR)、GATA3、核因子κB受体活化因子(RANK)、核因子κB受体活化因子配体(RANKL)、人表皮生长因子受体2(HER2)的IHC染色及HER2荧光原位杂交(FISH)结果的影响。三组在HE形态和IHC染色方面无显著差异。RapidCal组的抗原含量均完整;EDTA组的染色率相似,优于硝酸组(<0.05)。硝酸组细胞核Ki-67染色明显减少,但细胞质抗原(RANK、RANKL)的丢失少于细胞膜抗原(HER2)。对于FISH,RapidCal组和EDTA组结果相同,与IHC染色结果一致。硝酸组中HER2蛋白表达显著降低,17号染色体标记丢失(<0.05)。与传统脱钙剂相比,RapidCal处理的乳腺癌骨转移标本在形态学、IHC和FISH结果方面显示出优异的样本质量。由于EDTA脱钙时间较长,新型脱钙剂RapidCal在质量控制和临床应用中发挥着重要作用。

相似文献

1
[Comparative study of three different decalcifying solutions in bone metastasis specimens with breast cancer].[三种不同脱钙溶液在乳腺癌骨转移标本中的对比研究]
Zhonghua Bing Li Xue Za Zhi. 2017 Aug 8;46(8):536-541. doi: 10.3760/cma.j.issn.0529-5807.2017.08.004.
2
Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results.EDTA 脱钙处理乳腺癌骨转移不影响 ER、PR 和 HER2 检测结果。
Am J Surg Pathol. 2019 Oct;43(10):1355-1360. doi: 10.1097/PAS.0000000000001321.
3
Effect of EDTA decalcification on estrogen receptor and progesterone receptor immunohistochemistry and HER2/neu fluorescence in situ hybridization in breast carcinoma.EDTA 脱钙处理对乳腺癌中雌激素受体、孕激素受体免疫组织化学和 HER2/neu 荧光原位杂交的影响。
Hum Pathol. 2021 Nov;117:108-114. doi: 10.1016/j.humpath.2021.08.007. Epub 2021 Aug 27.
4
Effects of Decalcifying Agents of Variable Duration on PD-L1 Immunohistochemistry.不同脱钙剂处理时间对 PD-L1 免疫组化染色的影响。
Am J Clin Pathol. 2020 Jan 2;153(2):258-265. doi: 10.1093/ajcp/aqz161.
5
Effect of Hydrochloric Acid Decalcification on Expression Pattern of Prognostic Markers in Invasive Breast Carcinomas.盐酸脱钙对浸润性乳腺癌预后标志物表达模式的影响
Appl Immunohistochem Mol Morphol. 2017 Feb;25(2):144-149. doi: 10.1097/PAI.0000000000000277.
6
Evaluation of Decalcification Techniques for Rat Femurs Using HE and Immunohistochemical Staining.使用苏木精-伊红染色和免疫组织化学染色对大鼠股骨脱钙技术的评估
Biomed Res Int. 2017;2017:9050754. doi: 10.1155/2017/9050754. Epub 2017 Jan 26.
7
[Comparison of two different tissue decalcification methods for immunohistochemistry].
Beijing Da Xue Xue Bao Yi Xue Ban. 2011 Apr 18;43(2):290-4.
8
HER-2/neu analysis in breast cancer bone metastases.乳腺癌骨转移中的HER-2/neu分析
J Clin Pathol. 2009 Jun;62(6):542-6. doi: 10.1136/jcp.2008.059717.
9
Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.核因子κ B 受体激活剂的表达预测乳腺癌伴骨转移患者预后不良,但不预测伴内脏转移患者的预后不良。
J Clin Pathol. 2012 Jan;65(1):36-40. doi: 10.1136/jclinpath-2011-200312. Epub 2011 Nov 2.
10
Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.雌激素受体阴性和人表皮生长因子受体2阴性的乳腺癌组织具有最高的Ki-67标记指数和表皮生长因子受体(EGFR)表达:基因扩增对EGFR表达无影响。
Oncol Rep. 2005 Aug;14(2):337-43.